Dave Malenfant, healthcare supply chain expert, reflects on LogiPharma USA’s 20-year evolution, noting its shift toward greater diversity and inclusion, particularly with more women entering the ...
This episode of Pharma Pulse covers the potential ramifications of a federal government shutdown on FDA operations, Aetna’s newly announced 2026 Medicare Advantage offerings, and new research showing ...
Experts from Moderna, Revelation Pharma, and Alexion offer ways to reduce risks, improve real-time visibility, and ensure ...
Dave Malenfant, healthcare supply chain expert, gives his sneak peak into LogiPharma USA.
According to a new national poll from the PAN Foundation’s Center for Patient Research, 1 in the past 12 months, more than ...
From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.
Amid pressures on pharma to match the lowest international prices, experts warn of “policy laundering” and discriminatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback